




Pandemics/Epidemics – Challenges and Opportunities for Operations 
Management Research 
ABSTRACT 
We have reviewed research papers related to pandemics/epidemics (disease outbreaks of a 
global/regional scope) published in major operations management, operations research, and 
management science journals through the end of 2019. We evaluate and categorize these papers. We 
study research trends, explore research gaps, and provide directions for more efficient and effective 
research in the future. In addition, our recommendations include the lessons learned from the ongoing 
pandemic, COVID-19. We discuss papers in the following categories: (a) Warning 
Signals/Surveillance, (b) Disease Propagation Leading to Pandemic Conditions, (c) Mitigation, (d) 
Vaccines and Therapeutics Development, (e) Resource Management, (f) Supply Chain Configuration, 
(g) Decision Support Systems for Managing Pandemics/Epidemics, and (h) Risk Assessment. 
 
Keywords: Pandemic; Epidemic; Disease Outbreak; Anthrax; Cholera; COVID-19; HIV/AIDS; 
Influenza; SARS; Disaster Management.  
 
1. Introduction 
At the time of writing this paper, the whole world is engulfed in the fury of the COVID-19, a 
pandemic with its origin in China. Figure A1 in Appendix A shows the growth in the number of 
pandemic cases worldwide since its outbreak. A brief description of historical pandemics/epidemics, 
COVID-19 and its growth trajectory, and a description of diseases are included in Appendices A and 
B respectively. This pandemic has had profound social and economic impacts. Businesses around the 
globe were closed or had to work below capacity with greatly reduced market demand for extended 
periods.  
Given this grim situation, we set out to review the published literature with the hope of finding 
some appropriate solutions to the myriad of healthcare, social, economic and political problems that 
pandemics create. We review, categorize, summarize and synthesize 75 research papers related to 
pandemics/epidemics. We have used additional references listed in Appendix E to support our 
arguments and explanations. Then, we critically investigate trends and gaps to provide promising 
future research directions.  
There is no accepted scheme or framework for classifying research on pandemics. In our paper, 
based on available frameworks (see Appendix C for a review of available frameworks) and the topical 
coverage in the reviewed literature, we group our findings into the following categories: (a) Warning 
Signals/Surveillance, (b) Disease Propagation Leading to Pandemic Conditions, (c) Mitigation, (d) 




(g) Decision Support Systems for Managing Pandemics/Epidemics, and (h) Risk Assessment. The 
paper is divided into 11 sections. Figure 1 gives the roadmap for reading this paper. The paper ends 
with a list of references.  
 
Figure 1: The roadmap for reading this paper. 
 
A macro-level view of pandemic research is given in Appendix D. This appendix includes the 
methodology we used to search for relevant papers, a chronology of the growth in the number of 
relevant papers appearing in the pandemic literature, a list of the journals publishing relevant papers, 
the techniques that these papers used for analyses, and the type of data used by the authors of the 
relevant papers. 
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Pandemic surveillance systems are dependent on data sources such as hospital records, sale of 
pharmaceutical items, social media and news, and methods to identify anomalies that reflect public 
health issues.  
Zhang et al. (2009) and Fast et al. (2018) investigate how social media and online news reports 
can be used for syndromic surveillance using natural language processing. Zhang et al. (2009) use 
technical/professional news, whereas Fast et al. (2018) utilize general online news. Zhang et al. (2009) 
argue that a framework for monitoring and classifying online news for specific diseases will be more 
effective than a framework for general infectious diseases. To test their suggested framework, they 
use the major news-based syndromic surveillance systems in the field of infectious diseases such as 
ProMED-mail, Argus, MiTAP and HealthMap. After the online data acquisition and text document 
representation, a machine learning algorithm applies feature selection to the text, classifying, 
condensing and selecting the relevant features.  
Fast et al. (2018) study social dysfunction and disruptions (like anxiety, depression, riots, 
violence, etc.) during disease outbreaks. They utilize real data based on internet articles related to the 
outbreak of 16 diseases in 72 countries. Then, they apply Bayesian modeling and statistical process 
control to use the data and predict social response. The results show that the model performance is 
robust for prediction when there is substantial media coverage (i.e., at least 20 articles per year); but 
the model’s performance is not strong for little media coverage. Some factors that may cause paucity 
of media coverage include undeveloped online infrastructure, lack of a sufficient number of 
publication outlets, underestimation of perceived risk, and government censorship. The authors 
suggest alternative data sources like search engines, social media posts, medical supplies, satellite 
broadcastings, and meteorological data to increase model accuracy.  
Sparks et al. (2010a) and Sparks et al. (2010b) use hospital data to detect warning signals. Sparks 
et al. (2010a) study a surveillance problem as an early warning tool in the case of natural disease 
outbreaks or bioterrorism. They monitor data from a group of patients based on the similarity of their 
syndromes (called syndrome groupings). They call this type of research syndromic surveillance and 
use various transitional Poisson regression models and time series for forecasting. The parameters 
used in their models are the amplitude and location of the seasonal peaks, the one-day-ahead forecasts, 
and forecast errors. They form four syndrome groupings: respiratory, influenza, diarrhea and intestinal 
infections, and abdominal pain. The researchers observe that the Cumulative Sum (CUSUM) and 
Exponentially Weighted Moving Average (EWMA) may provide false alarms in the presence of non-
normality. Further, EWMA may not perform well for Poisson counts with low mean values. They 
monitor amplitude and seasonal peaks’ location and investigate errors for two models: adaptations of 
CUSUM and EWMA. Their research shows that adaptive EWMA is superior to CUSUM. Similar to 
Sparks et al. (2010a), Sparks et al. (2010b) study a surveillance system but the focus is on different 
diseases. Their suggested model accommodates patients’ behavioral data in recent past years over 




The main difference between this and prior research is that they do not consider standardized forecast 
errors and the assumption of normality. Accordingly, they propose an adaptive EWMA model which 
is effective for early detection by epidemiologists.  
Frisén (2014) adds time and location aspects and studies spatial outbreak detection methods for 
surveillance. The author studies four different locations and time of event scenarios using regression-
based techniques for multivariate surveillance: (i) detection of outbreaks in clusters that have 
increased incidences in geographically close regions; (ii) detection of an outbreak in an unknown 
location among many locations; (iii) simultaneous change (i.e., increase) of outbreaks at all locations; 
and (iv) outbreaks in different regions with time lags. To validate the methods, two evaluation metrics 
are used: false alarms and detection delay. The methods are tested for data related to seasonal 
influenza in Sweden. 
The above research studies do not consider uncertainty which is an important topic for future 
research in studying surveillance systems. Gailis et al. (2014) investigate how uncertainty in an 
epidemic’s early stages can be estimated. They propose a scenario-based tree to observe various 
possible paths that can be taken by an epidemic and syndromic signals. For the epidemic part, a 
stochastic SIR (susceptible, infected, recovered) model is utilized to consider the underlying social 
network and its connectivity. For the syndromic signals (e.g., absenteeism or rising sales for some 
pharmaceuticals items), beta distributions are considered that lag the epidemic. The authors generate 
time series for the epidemic and syndromic signals through simulation and feed these results to the 
scenario trees. Using data from the literature, the suggested method is validated based on accuracy in 
forecasting future outcomes. The authors show that the syndromic signals can provide a reliable early 
warning if the infected and non-infected people can be properly distinguished. 
 
2.1. Future Research Opportunities 
The research for early detection of an outbreak study both specific and general diseases based on 
either special-purpose data (e.g., health news and hospital data) or general-purpose data (e.g., internet-
based data). However, online data are not always derived by experts and analysts of healthcare 
systems. The dominant technique to analyze data is statistical analysis. Besides, scenario-based 
techniques (i.e., simulation and decision analysis), learning techniques (i.e., Bayesian network and 
machine learning) are also used.  
Research about the detection of new diseases – which is currently peripheral to health 
professionals – can be useful in terms of symptoms. There is a great creative opportunity in this 
domain. A network of doctors could be established to provide constant monitoring of healthcare status 
on a global basis as well as evaluations of the state of the systems. Observe unexpected spikes in 
absenteeism and spikes in demand for generic drugs which are pain killers, etc. Drug companies could 
provide valuable information time series data about generic drugs. Other observations could be 




surveillance problems deal with a large amount of data and a high level of uncertainty for which big 
data analytics, machine learning, and other learning-based models present attractive opportunities. 
This provides the chance to emphasize uncertainty applied to the study of surveillance systems. 
 
3. Disease Propagation Leading to Pandemic Conditions  
There is an elapsed time between the exposure to a pathogen and the appearance of the symptoms 
which is called the incubation period. The longer the incubation period, the more dangerous the 
situation becomes. Read Appendix B for a description of incubation period and 
reproduction/reproductive rate/ratio/number for various diseases. 
Kermack and McKendrick (1927) introduced the well-known compartmental model SIR in the 
field of epidemiology. In this model, a large population is split into three compartments: S 
(Susceptible), I (Infectious) and R (Recovered). An individual belongs to only one of these 
compartments and may move from one compartment to another. A system of differential equations is 
formed to show the flow between compartments at any time. Later, the SIR model was extended to 
SEIR, MSEIR, MSEIRS, SEIRS, SIR, SIRS, SEI, SEIS, SI, and SIS models depending on application 
for various diseases (Herbert and Hethcote, 2000). In these models, E represents the exposed 
compartment, and the M compartment stands for the passively immune class, such as infants with 
passive immunity. Gani (1987) extends and generalizes the two models developed by Kermack and 
McKendrick (1927) and Whittle (1955) based on the concept of a bunching model, which is attributed 
to Saunders (1980). The existing models may miscalculate disease outbreak if there is a bunching 
behavior where people collect in compact groups.  
 
3.1. Influenza 
Larson (2007) and Teytelman and Larson (2012) develop discrete-time models to study influenza 
pandemic progression. Larson (2007) focuses on the heterogeneity of the population. The behavior of 
a population, being socially active or inactive, can significantly affect disease propagation. This paper 
also studies “social distancing” as a behavioral control mechanism. Social distancing refers to the 
frequency and closeness of human-to-human contact and also includes quarantining. The author 
divides susceptible populations in terms of frequency of contacts and their infection propensity to 
show the disease’s evolution over time. Three models are analyzed: (i) active and inactive people, (ii) 
contacts over time, and (iii) social distancing and hygienic factors. The author uses a numerical 
example with existing data from nine countries. The research shows that social distancing can 
significantly control the outbreak as a non-pharmaceutical solution. If it is implemented effectively, it 
can even eradicate the disease.  
Teytelman and Larson (2012) generalize the model proposed by Larson (2007) by considering a 
continuous form of population heterogeneity, but time is still discrete. In their research, population 




infection, shedding virus and spreading infection. The research shows that the distribution of contact 
rates is highly important. In the initial periods of the outbreak, active people become infected and 
immune. Over time, inactive/low active people will dominate among susceptibles. 
 
3.2. HIV/AIDS 
Kaplan (1989) investigates the transmission of AIDS among gay men. The author models epidemic 
spread considering the incubation period of HIV and the duration of sex lives, which is the time a man 
enters an uninfected sexually active population until he leaves it. Following Kaplan (1989), Kaplan 
and Brookmeyer (1999) suggest a new method for estimating HIV incidence. In this research, a 
marker (that includes cellular concentration and immune-activation) shows time from infection 
available in the body of a person (named CD4) to estimate history and progression. The count of CD4 
via sampling at a point in time provides information about the infection in a population. The 
researchers suggest using a Markov model based on the marker. Such a method can be used in a 
prevention program and particularly for resource allocation. The authors state that their method is 
easy to implement, but the drawback is that it is still lagged into the past and may be biased for new 
infections. 
Griffiths et al. (2000) divide population under study into three subgroups: susceptible to infection, 
infected with HIV, and those who have developed AIDS. They draw flow diagrams to show how the 
disease is transmitted among different sub-populations within different age groups. The authors 
develop a system of differential equations and parametrically solve it. The research shows that the 
intervention policies, promotion of safe sex and the evaluation of cost savings by providing treatment, 
should target younger age groups (particularly those under 35). It means investing in older age groups 
is not worthwhile in terms of reducing the number of cases. 
Griffiths et al. (2006) extend the work of Griffiths et al. (2000). The authors observe that 
traditional models like SIR and SIS are not appropriate for HIV/AIDS because individuals cannot 
recover from this disease; only treatments and therapies can help affected people live longer. 
Therefore, they design an extended version of SI. Their model considers the following five sub-
populations at any time; the numbers of susceptibles, high-risk infectives, low-risk infectives, high-
risk AIDS cases, and low-risk AIDS cases. The authors use “difference equations” and solve the 
model. Depending on the types of treatments applied to people in different stages and times, and the 
natural history of HIV infection, the effect of drugs can be estimated. Using a maximum likelihood 
estimation procedure, the authors show that the model can be used to estimate future 
incidence/prevalence levels. The researchers test their model based on data related to the homosexual 
population in the UK and show its practicality and extrapolate the trajectory of the five variables. The 
results identify preventive measures to be applied to a population in the future. 
Roberts and Dangerfield (1990) and Xuan et al. (2009) use systems dynamics to examine the 




susceptible, HIV-infected, under treatment, clinical population and deaths. The model captures the 
incubation period and virological and behavioral features among these people. The authors draw an 
influence diagram for the disease transmission and solve their model using a system dynamics 
simulation software. They validate the model using UK data. Xuan et al. (2009) consider four groups 
whose behaviors are different in terms of infectivity, susceptibility, mobility and degrees of influence 
on others. The research considers the realistic state of an individual: healthy, dangerous, infected (but 
not infectious), infectious (but not asymptomatic), symptomatic, and deceased. The authors develop 
CA (cellular automata) simulation model to analyze the problem. Their research findings show that an 
HIV/AIDS epidemic can end up with either extinction or persistence. Factors such as population 
density, initial infection rate and mobility identify that the final result will be extinction or persistence. 
Moreover, while people who have very high infective susceptibility are few, they massively affect the 
infection rate and the outcome. Extensive documentation of the applications of systems dynamics to 
study AIDS can be found in a survey paper by Dangerfield (1999).  
 
3.3. Hepatitis C 
Hepatitis C can be transmitted in different ways such as unprotected sex, blood donation, tattooing, 
body piercing, mother to child and needle-stick. Mather (2000) simulates the spread of blood-borne 
diseases with a special focus on hepatitis C to evaluate the effects of interactions, immunizations, and 
treatment factors. The author considers a closed cohort of injecting drug users with three subgroups: 
susceptibles, infectives and immune. The researcher uses a Markov model and studies the progression 
of the disease. The research shows that only with a low interaction level and low probability of 
infection can a high prevalence level be prevented. The author believes that the proposed model can 
provide what-if analysis to investigate the impact of changes in parameters such as transition 
probabilities, disease prevalence within groups, the average number of contacts per week, probable 
immunization, treatment factors, and minimum duration in each state.  
 
3.4. Measles 
Yakowitz et al. (1992) investigate the application of automatic learning as a stochastic optimization 
algorithm that converges through repetition in epidemics. The research considers Markov states based 
on the SIR model for a general contagious disease. The SIR model divides people into susceptible, 
infected and removed (dead or immunized) at any point in time. As the epidemic develops over time, 
the population is partially immunized which reflects a learning process. This technique has been in 
use for measles, gypsy moth and crabgrass diseases (Durrett, 1988). The authors describe the 
applicability of the technique for spatial epidemic control. They study the immunization problem to 
show learning methods are applicable to epidemics. Accordingly, they compute the associated 
Markov probabilities. To do that, they apply the concept of dynamic Markov modeling - a variation of 




the state of the people as susceptible and infected that changes over time.  
 
3.5. Plague 
Carvalho-Rodrigues et al. (1993) explain epidemics based on the concept of entropy in 
thermodynamics. The concept of entropy has already been applied to complex systems like societal 
structures. Following the concept of the Shannon entropy model (Shannon, 1948a, 1948b), they see 
the concept as a predictor for the collapse of social cohesion when facing a disaster due to a disease 
outbreak. Empirical data was available about Lisbon’s plague for different periods from the 14th 
century to the 17th century. The authors consider the data for different zones of the city. For example, 
in seaports, more people are infected than in rural villages. The analyses on the existing data in terms 
of the numbers of casualties and combatants in different zones are conducted in different time periods 
(over several centuries). The research shows that if the mortality rate reaches around 37%, societal 
collapse happens. Collapse means the affected area goes into decline and is unlikely to be urbanized.  
 
3.6. Co-epidemics of HIV and Tuberculosis 
Long et al. (2008) study a co-epidemic problem, which means the spread of one contagious disease 
causes the spread of another one. An example of co-epidemic is the spread of HIV that can stimulate 
the spread of tuberculosis (TB). The authors develop two models for this problem. In the first model, 
they split people into susceptible and infected. In the second model, for the first disease, people are 
divided into susceptible, infected with no symptom, and infected with symptoms; for the second 
disease, people are divided into susceptible, exposed, and infected. The main decisions are whether to 
treat HIV or TB individually. Alternatively, coordinated treatment can be applied. The authors 
formulate the problem using a system of nonlinear differential equations and solve them analytically. 
The following equilibria have been defined and derived: disease-free equilibrium, quasi disease-free 
equilibria, and co-infection equilibrium. The research findings show that treatment efforts on a 
targeted epidemic may mitigate it but can worsen spread of the other. The authors recommend a 
coordinated effort in which both epidemics are treated. However, the researchers believe treatment by 
itself is not enough for the eradication of the diseases. Accordingly, coordinated prevention efforts are 
required.  
The final recommendation by Long et al. (2008) (i.e., treatment) is followed by Lebcir et al. 
(2010) who study HIV/AIDS, TB, and multidrug-resistant tuberculosis (MDRTB). These diseases and 
their treatments are interdependent. WHO has suggested using highly active antiretroviral therapy 
(HAART) for HIV/AIDS and some other drugs (named second-line drugs) for MDRTB for 
concurrent treatment. The research investigates HAART and MDRTB coverage levels considering 
their treatment rate and HIV and TB transmission dynamics. The authors draw a causal diagram based 
on the transmissions between TB, MDRTB and HIV to apply a system dynamics simulation model 




relationship between HAAR coverage and the number of deaths is not linear. If HAART coverage is 
less than 50%, its impact is not significant in reducing deaths from TB and HIV-associated TB. It is 
recommended the coverage to be above 70% to ensure significant impact. 
 
3.7. Future Research Opportunities  
We find that research on propagation, leading to pandemic conditions, is focused on diseases 
HIV/AIDS, influenza, tuberculosis, Hepatitis C and foot-and-mouth disease. Some recent studies have 
focused on co-epidemics that relate co-existence of two diseases. Various concepts like 
thermodynamics, automatic learning and rumor control have been used to model disease transmission. 
The existing research widely uses F&A data and it is reasonable to assume its continuity in the future 
due to data availability. At the same time, new developments in data mining and AI’s reliance on 
copious amounts of data provide exciting future research opportunities. 
In the future, research will continue to be virus-specific as the nature of the disease and its 
transmission behavior significantly affect modeling. Therefore, before modeling, broad-based 
knowledge of the studied virus is required. Another observation is that compartmental models are the 
backbone of pandemic modeling which applies to oversized and populous areas, but they may not be 
precise for small areas such as within hospitals which provides another research opportunity. Further, 
advancements in technology can enable researchers to develop efficient systems to support 
predictions about the control of disease propagation as well as other decisions. 
Systems dynamics may provide opportunities to expand the number of relevant variables, 
including behavioral factors, which are often crucial in determining the spread rate. In fact, human 
behavior is not widely understood and may play a greater role in efforts to control epidemic and 
pandemic levels. Human behavior is an important factor in the spread of coronavirus. So, it may not 
be that new models are required but rather that existing models be expanded to include variables that 
are considered difficult to quantify.  
 
4. Mitigation 
Mitigation refers to the pharmaceutical and non-pharmaceutical interventions that minimize the 
spread of disease. Pharmaceutical interventions include vaccinations, medicines and treatments, 
whereas non-pharmaceutical interventions include quarantine, isolation, social distancing, travel 
restrictions, numerical limits on public gatherings, school and business closings.  
We discuss two survey papers, Jaquette (1972) and Wein et al. (2009) that deal with mitigation 
issues. Jaquette (1972) reviews mathematical and quantitative decision theory models for epidemics. 
The paper shows that control theory, Markov decision processes and simulation, with 
deterministic/stochastic and continuous/discrete times have been used in epidemiology. However, the 
paper’s major contribution is introducing applications that are not limited to disease outbreaks. Wein 




attacks, namely anthrax spread, attacks on food supply, and pandemic influenza. 
 
4.1. Pharmaceutical Interventions 
Vaccines are pharmaceutical products that provide full or partial immunity to a specific disease by 
reducing transmission and mitigating outbreaks for a significant percent of the population. 
Vaccination programs have been the most effective approach to preventing widespread infectious 
diseases (CDC, 2011). To see various types of vaccines, review Callaway (2020).  
We have discussed below the cost-effectiveness of various mitigation alternatives, the 
enforcement decisions, and the importance of personal decisions. 
 
4.1.1. Cost-Effectiveness 
Methods for general diseases: Sethi and Staats (1978) find the optimal policy for vaccination 
levels. The state variables are the numbers of infected and susceptible people; the control variables are 
the levels of medicare and inoculation program efforts. Three mathematical models are suggested. 
Like Sethi and Staats (1978), Lefevre (1981) studies a contagious disease in a finite population 
divided into infectives and susceptibles. The disease can be transmitted from infectives to susceptibles. 
Some infected people recover. Using a discrete-time Markov chain, the authors model the problem as 
a birth-death process and solve it analytically. The objective function is the minimization of 
discounted cost over an infinite time horizon. The cost function is the summation of the social cost 
(based on the number of infectives) and control cost (per unit time adopting quarantine). The 
researcher shows that this problem is similar to a rumor control problem where an external source 
(e.g., newspapers and television) acts similar to an infection process.  
Piunovskiy (2004) considers the number of susceptible people and disease carriers as the state 
variables at a point in time. The jump from one state to another is not controllable. The problem is 
modeled as a continuous-time-jump Markov process and formulated as a dynamic programming 
problem. There are two performance criteria: the total (expected) number of susceptibles who have 
been infected and the total (expected) number of susceptibles who are immunized. Both criteria are to 
be minimized in the Bellman dynamic programming equation to find the optimal intervention strategy. 
Methods for specific diseases: Zaric et al. (2000) investigate the cost-effectiveness of methadone, 
a drug used in heroin addiction treatment. The researchers divide the population into three categories: 
uninfected, HIV infected without AIDS, and infected with AIDS. They also consider three risk groups 
for injection drug users (IDUs): IDUs who are not in treatment, IDUs who are in treatment, and non-
IDUs (who do not inject). These two categorizations make nine compartments of the population. 
Infection can be transmitted in two ways: sexual contacts and drug injection. Healthcare and 
medication costs/benefits measured in terms of quantity and quality of life are analyzed. The authors 
explore the transition rate among the nine different compartments and form an associated system of 




research shows that the methadone program is cost-effective, even in groups with low HIV incidents. 
Additionally, the greatest cost savings in the healthcare system have occurred because of HIV care 
cost-saving. 
Whereas Zaric et al. (2000) implicitly consider that there are sufficient vaccines available for the 
whole population, Kress (2006) considers the possibility of limited vaccine supply and, therefore, the 
need for an inevitable prioritization. Kress (2006) considers a bioterror attack with a contagious virus 
(here, smallpox) that can cause an epidemic. The research investigates response policies against such 
an event as epidemic-intervention: (i) mass vaccination that uses the overall capacity to cover the 
whole population, (ii) trace vaccination (also called ring or targeted) that uses a limited vaccination 
capacity and applies to infected (or suspected) people, and (iii) prioritized vaccination process (PVP). 
In PVP, the trace queue has priority; then, additional vaccination capacity is used for the general mass 
queue. This virus has an incubation period and will be asymptomatic for a while. The author assumes 
that infected people are not infectious during the incubation period and divides the incubation period 
into two smaller periods as immunable and non-immunable. During the immunable period, which is 
also called vaccine sensitive, vaccine is effective and there is a high chance to eliminate the disease 
from an infected person. During the non-immunable period, vaccine cannot eliminate the disease and 
the infected person will be ill in the end. After the incubation period, the individual will be infected 
with symptoms. Effectiveness, based on the maximum tracing probability, shows that the most 
effective policy is PVP (see iii above). 
 
4.1.2. Implementation Issues  
Swine influenza vaccination: Zalkind and Shachtman (1983) suggest a decision tree analysis to 
estimate the non-economic value of life/death. The authors use the term “non-economic value of 
life/death” as a surrogate for the probability of death. Their suggested method works based on the 
decisions made by individuals. A person decides whether to receive the vaccine considering its 
positive and negative consequences. The data related to the values, probabilities and consequences 
regarding the reaction to a flu jab, contracting swine influenza, dying from swine flu, the chance of 
swine flu occurrence and vaccine efficacy are included in the decision making process. The research 
uses lottery construction in modeling and analysis. The authors believe that a decision tree is an 
appropriate tool for determining the non-economic personal value of life in a situation like epidemics 
when dealing with an individual’s decision. An adverse event may(not) happen. An individual 
may(not) accept vaccination. In either case, there can be positive and negative aspects. 
Hepatitis C: Behrens et al. (2008) study the spread of the hepatitis C virus (HCV). From among 
its various transmission modes, the research focus on contaminated tattoo equipment. Sterilization of 
equipment can solve the issue but it incurs an additional cost of around 15% per tattoo, causing 
resistance from businesses. The research investigates possible interventions to be examined by the 




include the number of sterilizations and HCV infections over time. By using real data, the authors 
conduct sensitivity analyses. Their findings show that intervention via regulating and enforcing tattoo 
parlors is cost-effective for HCV control. 
Treatment prioritization for hepatitis C: Ayer et al. (2019) investigate how prisoners suffering 
from hepatitis C virus (HCV) infection need to be prioritized for treatments. The appropriateness of 
prioritization is identified based on criteria such as liver disease and remaining sentence length (short 
or long). The objective function is to minimize the quality-adjusted life years (QALY) that considers 
both (i) reduction in an infected patient’s life expectancy/quality and (ii) potential value loss from 
future transmissions. The authors model the problem mathematically and solve it by using agent-
based simulation. The common practice is prioritization based on only liver health status. The 
research shows that unlike current practice, remaining prison sentence length and IDU status should 
also be considered with the liver health status.  
 
4.2. Non-Pharmaceutical Interventions 
Non-pharmaceutical interventions focus on social distancing to reduce contact among people. They 
also include masks, hand-washing, hand-sanitizers, contact tracing, etc. Research opportunities about 
the effectiveness of various strategies for each of these categories are blatantly evident. For example, 
most masks that people wear are in no way related to the standards of the N-95. What effect does the 
constant touching by people of their individual masks have in diminishing the benefit of masks? We 
could go on in the same vein with respect to hand-sanitizers and bogus marketing, contact tracing and 
the refusal of many to cooperate,  
 
4.2.1. Quarantine and Isolation 
Quarantine for a general disease: Sethi (1978) divides populations into susceptibles and 
infectives and formulates a quarantine problem to be used as a lever by authorities to control a disease 
outbreak. The model contains a control variable that continuously changes between 0 and 1 to adjust 
the contact rate between people. The author formulates the problem with a linear social cost function 
for an infinite horizon and solves the problem analytically using a mathematical model with 
differential equations. Eventually, the model is extended for a finite horizon application (e.g., seasonal 
influenza). 
Isolation for Ebola: Büyüktahtakın et al. (2018) study the spatial spread of infectious diseases 
between susceptible, infected, treated, recovered, and dead people. The model dynamically 
determines when and how much of the existing resources need to be assigned to various locations. 
The model minimizes the sum of infected people and fatalities subject to budget and capacity 
limitations. The research shows that immediate isolation (i.e., reducing contact rate), improving 
recovery rates, precautions in funeral and burials, and education significantly affect the number of 





4.2.2. Travel Restrictions 
Travel restriction for influenza: Nigmatulina and Larson (2009) follow Larson (2007) to study 
how to mitigate the spread of pandemic influenza. This research adds travel restriction to the 
previously studied strategies (i.e., social distancing and hygiene) to investigate the impact of 
interventions to stop virus spread. Moreover, it considers several heterogeneous communities that are 
loosely linked. They develop a mathematical model for their multi-community problem to observe 
spatial spread. The research indicates that non-pharmaceutical intervention can make a significant 
difference even if vaccination is not used. The authors do not recommend that governments enforce 




Adherence, a term linked to behavioral psychology in healthcare, is defined as “the extent to which a 
person’s behavior, taking medication, following a diet, and/or executing lifestyle changes, 
corresponds with agreed recommendations from a health care provider” (Chakrabarti, 2014). 
Similarly, McCoy et al. (2014) define a patient’s adherence as his/her willingness and commitment to 
a treatment program. They consider adherence and the growth of epidemic diseases simultaneously in 
a capacity planning problem to investigate the effectiveness of treatment. This research assumes that 
people who are geographically close to their health providing facilities maintain a higher level of 
adherence. Patients are heterogeneous and may not have the same commitment to adherence for 
various reasons. For example, patients who live in rural areas, far from their health facilities, may 
have less adherence. The researchers suggest a nonlinear mathematical model that determines the 
number of patients to be enrolled in a specific clinic. The objective function minimizes the average of 
the infected population in future periods subject to a budget limit. The model is analytically solved. 
The authors use real data related to HIV of rural Zambia and show that ignoring adherence and health 
delivery can significantly overestimate the effectiveness of a treatment program.  
 
4.2.4. Hybrid Interventions 
Mixed strategies for influenza pandemics: Das et al. (2008) design a simulation model for 
controlling influenza outbreaks. The model considers the stochastic spread of the disease and shows 
the impact of a pandemic based on measures such as the number of infectives, deaths, people denied 
hospital admission, denied vaccines, and total cost, including healthcare costs and wages. Various 
mitigation strategies can be applied to the model to observe the impact of vaccination, prophylaxis, 
hospitalization, social distancing, and voluntary and mandatory quarantine. The model is tested by 
using hypothetical data. The authors suggest a framework that works based on a Markov decision 




Pharmaceutical and non- pharmaceutical strategies for H5N1: Uribe-Sánchez et al. (2011) 
investigate a resource utilization problem considering societal and economic dynamics. They study 
dynamic and predictive mitigation strategies for a pandemic outbreak and develop an optimization 
model to determine mitigation strategies for health policy makers. The possible mitigation strategies 
are pharmaceutical (e.g., vaccine and antiviral) and non-pharmaceutical (e.g., social distancing). The 
objective of the model is to minimize the costs of lost productivity and medical expenses. These cost 
items are linked to morbidity, mortality, and social distancing. They formulate the problem based on 
the SEIR model and solve it by a simulation-optimization algorithm. The research findings show that 
(1) vaccine efficacy for low transmissibility scenarios is not significant compared to high 
transmissibility scenarios; (2) social distancing conformance significantly affects the pandemic cost, 
particularly for higher transmissibility scenarios; (3) early declaration of social distancing will 
significantly decrease the number of infected people and deaths. 
Ventresca and Aleman (2014) investigate the containment phase of disease spread applied to 
vaccination, quarantine or isolation. The problem is to choose a subset of nodes in a network exposed 
to a contagious disease so that the number of affected nodes is less than a given number. It is assumed 
that the disease affects the population, starting with a single individual. Each node in the graph has a 
population size that determines the probability of an outbreak in that node. If a node contains an 
infected individual, then all people in that node are likely to be infected. The authors formulate the 
problem as an integer programming model to minimize the number of nodes to be removed. The 
authors suggest a local search algorithm to find near-optimal solutions. The researchers validate the 
algorithm against four benchmark models, namely Erdös–Renyi, Barabasi–Albert, Watts–Strogatz 
small world, and forest fire (Leskovec et al. 2005). 
 
4.3. Future Research Opportunities 
Mitigation of pandemics/epidemics, using simulation and stochastic modeling, has been a popular 
research area over the last two decades. The intervention strategies for mitigation are divided into 
pharmaceutical, non-pharmaceutical, and hybrid. In pharmaceutical interventions, cost-effectiveness, 
enforcement and individual decisions have been investigated for general and specific diseases. When 
it comes to non-pharmaceutical interventions, quarantine, isolation, travel restriction, and adherence 
are studied. Finally, few research papers have considered a mixture of pharmaceutical and non-
pharmaceutical interventions. A critical gap in the research is the lack of focus on research in 
healthcare supply chains (SCs) where hospitals and emergency departments are involved. Also, there 
are very attractive modeling concepts that can be pursued such as the rumor control problem where 
external sources such as tweets and Facebook messages can be studied as analogs to disease infection 
processes. 
The research on pharmaceutical intervention is effective if they focus on the specific disease 




be extended to many other unexplored diseases. In particular, we recommend researchers to consider 
COVID-19. The research on non-pharmaceutical intervention is also either on general disease or 
specific ones like Ebola and influenza. However, the existing non-pharmaceutical approaches are 
commonly effective for most contagious diseases. In case of COVID-19, we observe that some 
nations enforce such guidelines and some others recommend it. It is an important research direction so 
see under what conditions these approaches should be applied voluntarily or enforced. 
 
5. Vaccines and Therapeutics Development  
Developing an effective vaccine for a new disease is a complicated, costly, and time-consuming 
challenge (Oyston and Robinson, 2012). After identifying the virus strain, vaccine development 
requires testing, bulk manufacturing, quality control, batch filling and distribution, and release. In 
case of new viruses, major uncertainties are identifying, preparing, and verifying the vaccine strains 
(WHO, 2009).  
 
5.1. Vaccine Development 
Wu et al. (2005) investigate a vaccine strain selection problem focusing on influenza viruses. Annual 
influenza vaccines are based on the virus’ historical evolution because influenza evolves in a random 
sequence of mutations (so-called antigenic drift). How to formulate and develop vaccine-strains is 
computationally complex because it is a high-dimensional, multi-period, stochastic process. All 
potential vaccines are mapped with respect to efficacy and safety against each identified viral type of 
the epidemic. Dynamic programming is then used to find a near-optimal, closed-form approximation 
for a single-period version of the problem. Research shows how such a multi-period complex problem 
can be tackled by solving a series of single period problems.  
 
5.2. Vaccine Allocation 
5.2.1. Timing in vaccination 
Yarmand et al. (2014) consider a vaccine allocation problem for an infectious disease like influenza in 
two phases. In phase one, vaccine doses are allocated to regions with the objectives of cost 
minimization and containing the outbreak. In phase two, additional doses of vaccine are allocated 
with the same objective but for regions in which the epidemic is not contained. The authors simulate 
the problem as a two-stage stochastic formulation which they convert to a linear model; develop a 
newsvendor equivalent of the problem, and suggest a heuristic algorithm. Their research shows that 
epidemic alerting and detection is valuable only if vaccination coverage in phase one is low. 
Similar to Yarmand et al. (2014), Duijzer et al. (2018a) also study timing in vaccination but focus 
on changes in vaccine type rather than using the same vaccine in different phases. The authors study 
timing for choosing between a specific or an aspecific vaccination. Aspecific vaccines are available 




Specific vaccines are those that are designed and produced after a known pandemic happens. 
Aspecific vaccination may prevent a large outbreak, but specific vaccination has an advantage as it is 
tailor-made and more effective. Therefore, specific vaccines are efficient but will be available late 
when many people are affected. There are two approaches to avoid an outbreak: (i) aspecific 
vaccinations in the early stages with limited information on the disease, and (ii) specific vaccination 
later. Using the SIR model, the authors formulate the problem mathematically to calculate the fraction 
of people who are not susceptible and immune. The objective function is the minimization of the 
infected proportion of the population. Trade-offs between timing, efficacy and controlling the 
epidemic show that an optimal strategy is not to spend the budget on a single strategy; a hybrid 
strategy that contains both approaches is best. Based on the data in the literature related to H1N5, the 
findings show that vaccinating a fraction of the population at the early stages (with aspecific vaccine) 
and, after a while, switching to the specific vaccine can reduce infection rates by at least 50%. 
 
5.2.2. Geographically different regions/ populations 
While Duijzer et al. (2018a) investigate the vaccination problem in terms of timing, Duijzer et al. 
(2018b) focus on multiple, non-interacting populations. They highlight two ways to achieve immunity: 
vaccination (direct effect) and herd immunity (herd effect). Herd immunity refers to the scenario 
when a sufficiently large number of people in a community are immune to a disease (by vaccination 
or by recovering from the diseases that often bestow immunity. In such cases, the community is 
immune as propagation of the disease through individuals is unlikely (MFMER, 2020). This research 
investigates which population groups should be under direct effect and which groups should be under 
herd effect when there is a limited vaccine stockpile. The objective is to maximize the number of 
people who escape infection. Based on the SIR model and SEIR (an extension of SIR), the authors 
formulate the problem mathematically to decide what fraction of the population needs to be 
vaccinated. The research shows that allocating the limited vaccine stockpiles based on multiple doses 
for some populations is more effective than equally using a single dose to all people. However, they 
believe that this approach can be criticized on ethical grounds.  
 
5.3. Insourcing/Outsourcing of Mass Production 
Adbi et al. (2019) empirically investigate pandemics in emerging economies, focusing on the H1N1 
influenza vaccine in India. They state that in India, vaccines are supplied through either domestic or 
multinational organizations. The main research question is how domestic and multinational 
organizations should respond to a shocked demand caused by a pandemic in a developing country. 
Further, they study how targeted policies - such as advance commitments/contracts for the response 
phase, and providing incentives for domestic suppliers/ manufacturers to develop new vaccines and 
therapeutics - can help in such pandemics. By using vaccine purchasing data from India during the 




newly developed vaccines and therapeutics in the case of a pandemic. Sufficient incentives need to be 
provided for domestic manufacturers. This arrangement is preferred to advance contracts with 
multinational suppliers. 
 
5.4. Future Research Opportunities 
Vaccine development continues to be in the domain of researchers in pharmaceutical companies. This 
area remains unexplored by the OM community. However, it can benefit from OM research in the 
“new product development” field. Unlike profit motivations in commercial markets, incentives can 
include humanitarian considerations that are wielded by society as well as governmental agencies. 
The OM community can also contribute to the development of superior logistics of vaccine 
distribution. 
There are research potentials for unknown viruses that evolve over time requiring new specific 
vaccines. Designing and producing new vaccines takes a long but uncertain time. On the other hand, 
there are always some medicines and vaccines available before a pandemic. Using these specific 
vaccines may save time, cost, and lives if they mitigate the impact of a sudden pandemic. 
Investigating the nature of viruses, (dis)advantages of the early specific vaccination, the timing and 
target population to be vaccinated as a quick mitigation approach can be important topics for future 
research. The focus of this paper is on vaccines and therapeutics for pandemics/epidemics. In that 
regard, readers interested in influenza can refer to Keskinocak and Savva (2020), Deo and Corbett 
(2009) and Cho (2010) that focus on influenza. 
 
6. Resource Management 
6.1. Hospital Capacity 
Sun et al. (2014) study collaboration between several hospitals to allocate patients in the case of an 
influenza pandemic. The model has two objective functions: minimization of patients’ (i) total travel 
distance and (ii) the maximum travel distance to hospitals. The decision to be made is to allocate 
patients to hospitals. The constraints are the availability of critical personnel and vital equipment. The 
problem is formulated as three linear models: a single period model considering objective function (i); 
a bi-objective multi-period model by adding objective (ii) as a proxy for equity between patients; and 
a bi-objective model by adding hospital resource limitation constraints to the second model. The 
authors use the constraint method to convert models with two objectives to a single objective model.  
Sun et al. (2014) study patient allocation without considering implementation aspects. Liu and 
Zhang (2016) suggest four phases comprising forecasting, planning, execution, and adjusted 
forecasting (FPEA) that work continuously as a closed-loop. They implement these phases and apply 
them to medical resource allocation in epidemics. The forecasting phase works based on the SEIR 
model. In the planning phase, a multi-period, mixed-integer model decides whether or not each 




costs for supplying, distributing and allocating hospital beds. Moreover, a quadratic programming 
model is used for the execution phase. The model is adjusted periodically to minimize errors. The 
four-phase loop is tested on hypothetical data. 
In contrast to the above research, Long et al. (2018) design a two-stage model to consider the 
heterogeneous geographic spread of epidemics. In the first stage, they utilize historical data related to 
21 regions of the 2014 Ebola epidemic in the West African countries to anticipate the outbreak’s 
trajectory at the regional level. This anticipation is based on calibrating a dynamic epidemic model. Its 
robustness is tested against the basic SIR model. The problem is formulated and solved using a set of 
nonlinear differential equations. In the second stage, four resource allocation approaches based on 
greedy, myopic, and dynamic policies are examined for bed allocations, assuming that there are a 
sufficient number of beds. The performance of these allocation approaches is compared by using 
training data in different periods and under different budgets. The findings show that the myopic 
policy performs better than the other methods. 
 
6.2. Bioterror Attack in Airports 
Berman et al. (2012) study a resource allocation problem focusing on a bioterror attack on airports. 
They assume that an unknown number of infected passengers can transmit the disease to other 
susceptible passengers. They consider allocation of limited resources such as vaccines, human 
resources and antibiotics to airports in different cities. Given that the number of passengers flying 
through each airport is different, the objective function is to minimize the total expected number of 
deaths. They formulate the model with the SEIR model for vaccination embedded in it and use 
Lagrangian relaxation to solve an approximate version of the model and drive a closed-form solution. 
They expand their model to minimize the maximum number of deaths.  
 
6.3. Staffing in Mass Immunization 
Rachaniotis et al. (2012) study resource allocation of medical teams. The SIR model is used to 
calculate the disease spread rate. The objective function is to minimize the number of infected people. 
Borrowing from the scheduling literature, a job's processing time may increase because of a long 
waiting time before processing. Such jobs are considered deteriorating jobs (Mosheiov, 2005). The 
case study includes a medical team's assignment to vaccinate older people over 80, who cannot go to 
the vaccine centers. In reality, a random system was used to vaccinate people with appointments 
based on telephone requests. This system did not significantly impact the infection rate due to various 
reasons, including the shortness of the time for administering vaccines. If the proposed assigned 
medical teams are used, the number of infected people will decrease significantly compared to the 
random model. The research shows that the number of infected people is not impacted by an increase 
in the initially infected people. 




(2014) optimize staffing decisions by presenting a discrete-event simulation method for mass 
immunization clinics (MICs) that is important for local authorities. The model considers several 
scenarios like the peak-capacity (baseline), full capacity and overloaded system. It also adopts 
realistic aspects of the problem like waiting times (including reneging and balking), and societal/ 
economic losses (estimated as the minimum cost for the waiting times of patients, nurses, etc.). Note 
that shorter waiting times can also reduce the exposure time and disease propagation rate. The 
research shows that there is no need to hire additional staff in such situations. If the current staff 
works at full speed, productivity will be the highest. 
 
6.4. Future Research Opportunities 
Resource management in pandemics/ epidemics has drawn the attention of OM researchers over the 
past decade. The most popular technique is mathematical programming using largely F&A data. The 
topics studied include bioterror attacks in airports, staffing in mass immunization, hospital and bed 
allocation, and vaccine allocation. Since the area is close to the OM community's expertise, OM 
researchers can contribute significantly to further research. 
Investigating surge capacity of hospitals during a pandemic is an important research topic. 
Evaluation of multiple vaccine candidates when a new pandemic is involved (such as COVID-19) 
becomes a crucial area for research. This is particularly true when the candidate vaccines' production 
must occur before each candidate is fully tested, evaluated, and one or more is accepted. Situations 
where some vaccine candidates require multiple shots before becoming effective while others provide 
a sufficient level of protection with a single shot only require attention. An important potential OM 
research topic deals with establishing MICs that might provide a disruptive approach to traditional 
vaccination programs. 
 
7. Supply Chain Configuration 
There are two review papers in this area which are Dasaklis et al. (2012) and Brandeau (2019). 
Dasaklis et al. (2012) divide the literature into (i) preparedness, outbreak investigation, response and 
evaluation, and (ii) surveillance, hospitals/ pharmaceutical and (iii) physical logistics resource 
allocation. The authors list the details of activities and split the papers along two dimensions: (1) 
disaster type that includes bioterrorist and natural outbreaks, and (2) timing that includes pre-event, 
post-event, and integrated. They analyze each paper in terms of objectives, constraints, assumptions, 
etc. The research shows that most logistics operations papers focus on epidemics logistics network 
configuration, stockpiling medical supplies, and triage operations. 
Brandeau (2019) reviews papers related to preparedness for bioterrorism attacks or disease 
outbreaks and, specifically anthrax, one of the deadliest forms of biological terrorism. It does not have 
any indicators (e.g., no color and no smell). Since two antibiotics can be used to prevent the disease, 




solution. The major logistical challenge is not the availability of the inventory nationwide; it is a 
limitation in the dispensing capacity because in 48 hours all infected people need to have access to the 
antibiotics. The paper introduces stockpiling strategies at all homes, workplaces, pharmacies/ 
hospitals, and nationwide. Each of these strategies has advantages and disadvantages in terms of cost 
and response time that can be investigated.  
 
7.1. Coordination between Governments and Organizations 
7.1.1. Nationwide vaccine SC 
Influenza vaccine SC: Chick et al. (2008) consider a seasonal flu vaccine SC with two players: a 
government and a manufacturer. The manufacturer produces a vaccine quantity to maximize 
(minimize) its expected profit (net cost) in an uncertain situation. Like in the newsvendor problem, 
additional vaccine produced this year cannot be used for the year after, while producing less than the 
demand results in lost sales. The government considers a fraction of the population that needs to be 
vaccinated. Accordingly, the government will order an amount of vaccine from the manufacturer to 
minimize its total cost, including purchasing and health costs. The authors solve the two-player game 
and show that it has a Nash equilibrium. The researchers assess a contract setting such as wholesale 
price and payback, and incentives to see if the players can collaborate to reduce their overall financial 
and health costs. This research shows that wholesale price and payback contracts cannot satisfy the 
two SC players for their own objectives/ constraints. A special type of cost-sharing and coordinating 
can improve cost-benefit in public health and provide incentives for both players. 
Shamsi et al. (2018) extend Chick et al. (2008) by (i) considering a backup supplier to overcome 
uncertainties and (ii) adding a new social cost objective. An option contract is developed between a 
buyer, a governmental organization, and two vaccine suppliers. One of the suppliers is the main 
supplier with a specific capacity and price. The other one is the backup supplier, which is more 
expensive but ensures a reliable supply for covering any uncertain demand above the first supplier's 
capacity limit. The problem is formulated as a Stackelberg game, where the buyer is the leader trying 
to minimize procurement and social costs (minimizing the infected people and maximizing the 
recoverable people). The suppliers are followers and maximize their incomes. The main decision 
variables are the number of orders from the leader to each supplier. Based on the SIR epidemic model, 
the authors use available data and apply their model to Iran's case. Their findings show that if there is 
no pre-disaster contract option, the social cost will increase due to the long lead time of vaccines 
compared to the contract option’s lead time. This fact may apply to the buyer’s procurement cost to 
provide the vaccines obtained from national or global markets. The buyer should order from both 
suppliers to keep the market competitive. This approach will not allow the suppliers to increase their 
prices. 
Partnership in urgent health services: Gibbons and Samaddar (2009) investigate how a 




partnership network for efficient vaccine delivery. Efficiency is defined as how quickly people can be 
vaccinated, given the limitation on the available vaccines. They conduct simulations for a city of 
thousands of inhabitants who need to receive vaccines in a short time. Regarding an appropriate place 
to be vaccinated, the government can provide advice to people based on a pre-determined priority list 
or people can randomly search. The results show that forming a partnership between producers and a 
small number of distributors significantly improves the delivery system's performance. Therefore, the 
distributors with a higher capacity are not necessarily the best choices to receive a referral. The 
researchers recommend forming a partnership with a few distributors based on their locations and 
capacity, and refer patients daily.  
Overlapping disasters: Rottkemper et al. (2011) investigate inventory relocation in areas affected 
by a sudden increase in demand due to overlapping disasters. For example, when relief operations 
were ongoing in the Haiti 2010 earthquake, hurricane Tomas struck. In such situations, some areas 
may have excess inventories and other areas may face shortages. The authors develop a mixed-integer 
and linear model in a multi-period setting to decide how much inventory from each region needs to be 
transported to other areas. The objective function is to minimize cost including transportation, 
inventory replenishment and inventory holding costs and penalty costs related to shortages and 
unsatisfied demand. The authors test their model on a realistic example in a vaccination program in a 
rural area in east Burundi. Due to higher uncertainties about future periods, the authors suggest the 
model be used on a stepwise rolling horizon basis. The research shows that the solutions obtained 
from a rolling horizon setting with certain parameters provide higher quality solutions (unsatisfied 
demand and total cost) than when considering uncertainty. 
 
7.1.2. International vaccine SC  
Containment: Chick et al. (2008) and Shamsi et al. (2018) investigate a vaccine SC at the 
national level, whereas Sun et al. (2009) and Mamani et al. (2013) study interrelated issues between 
several countries. Sun et al. (2009) investigate a vaccine stockpile problem among multiple countries 
in the case of pandemic influenza. They consider country 0, where the epidemic starts. Each county 
has a fixed population size and needs to decide how many vaccines to store to minimize the expected 
number of infected peoples. The research uses a game model to examine how different countries 
decide about their vaccine stocks if an epidemic starts in a country with little or no vaccine inventory. 
The decisions are how many vaccines should a country give up to country 0 and how much to keep 
for its future use. The authors use a multivariate Reed-Frost model to calculate disease spread within a 
country and across counties and obtain the Nash equilibrium in this game. The findings show that if 
the transmission rate between countries is low and there is no central planner like WHO, a country 
(other than country 0) will supply all of its existing drugs to country 0 and not give it up to any other 
country. Moreover, if there is a central planner, all countries can make a fair agreement on an 




Influenza vaccination: Mamani et al. (2013) design a mechanism to coordinate several countries 
for the allocation of seasonal influenza vaccines by using a game-theoretic concept. Similar to Sun et 
al. (2009), they assume that the outbreak starts from a source country and calculate the Nash 
equilibrium. Through numerical experiments, they show that their model reduces overall infection 
costs and the number of infected people. The research shows that a country should not design its 
vaccination policy individually; it needs to be based on transmission rates between countries. 
 
7.2. Food Home Delivery 
Ekici et al. (2014) investigate food preparation for people who do voluntary quarantine during an 
influenza pandemic. They apply an agent-based disease spread model to anticipate the disease’s 
spread. Then, a multi-period, multi-echelon facility location problem is developed for food SC 
network design. The disease spread model is used to find the demand for food. The objective function 
is to minimize the total costs, including transportation costs. Points of deliveries (PODs) are schools, 
churches, community centers, and businesses. Demand nodes are households. The main variable is the 
number of meals sent from supply points to PODs and from PODs to demand nodes. Supply points 
are grocery stores and charity foundations. Two heuristic approaches are introduced to solve the 
problem: static (STAT) and dynamic (DYN). The STAT can work well for in-advance planning since 
it estimates the disease's spread and the demand for food for the initial periods. DYN can be used in 
the implementation stage as it updates all parameters over time. The solutions are applied to test 
problems from several counties in the U.S. The research shows that a voluntary quarantine decreases 
capacity bottlenecks and disruption of the food SC. When shipment cost decreases during quarantine, 
the total cost will increase compared to the no intervention case. On the other hand, the lower 
shipment cost will lead to a lower quality of service (defined as the percentage of demand that is 
satisfactorily serviced served from a POD within 10 miles of the demand location) since more demand 
will be received from greater distances. Gui et al. (2019) study the effectiveness of various strategies 
to replenish micro-retailers in remote areas and show the benefits of cooperative strategies for 
consumer welfare. Such strategies to serve remote areas gain importance for pandemics and other 
extreme disasters.  
 
7.3. Logistics and Physical/ Psychological Fragility 
He and Liu (2015) investigate how physical and psychological fragility can be reduced in epidemics. 
Physical fragility is a function of the amount of emergency supplies sent to a specific group of people. 
The more items supplied to meet demand, the lower is physical fragility. Psychological fragility is the 
fear generated in people from different groups who are susceptible or exposed and infected. They 
modify the SEIR model and use it to decide the optimal amount of medical supplies dispatched from 
each emergency medical reserve center to each of the affected areas in a multi-period setting. The 




psychological fragility measured based on unsatisfactory amounts of treatment relief. The model is 
solved by using commercial software and tested on real data related to SARS in China. This research 
shows that survivors’ psychology can significantly improve psychological fragility for the affected 
people.  
  
7.4. SC Network Design in Developing Countries 
7.4.1. Niger vaccine SC 
Based on the WHO’s Expanded Program on Immunization (EPI), Chen et al. (2014) study a vaccine 
SC in developing countries and investigate how it can be designed to work more efficiently. The 
current vaccine SC has four levels, which are expanded from national, regional, district and clinical 
levels to reach recipients. At each level of the vaccine SC, there is a limited capacity of facilities such 
as refrigerators and freezers that can keep the vaccine for a long time. The authors suggest a linear 
program model to optimize inventory and distribution decisions in the vaccine SC. The model’s 
objective function maximizes the number of Fully Immunized Children (FIC) plus additional vaccines 
to be stored in the locations that have spaces. The authors also expand the model by including 
minimization of the total capacity investment cost. The model is tested in the Niger’s vaccine SC 
network to analyze scenarios such as removing a distribution level, changing vial size, and 
introducing new vaccines and capacity expansion. The research shows that removing a level in the SC, 
namely removing the regional stores, does not significantly improve the efficiency of the existing SC 
network.  
 
7.4.2. Healthcare SC network in Haiti 
Anparasan and Lejeune (2018) and Anparasan and Lejeune (2019) study a location-allocation 
problem in Haiti based on data from the cholera epidemic after the Haiti 2010 earthquake. The first 
paper introduces a dataset that contains information about the number of geographic locations of 
patients and location/capacities of hospitals (e.g., the number of staff) for 120 days. Anparasan and 
Lejeune (2019) use this dataset in an integer linear programming (ILP) model to determine the 
number, size, and location of healthcare facilities, location of ambulances in triage points to transport 
infected patients to treatment facilities. The objective function maximizes the number of infected 
people transported from triage to treatment centers. There are three types of treatment facilities that 
differ in capacity and range of treatments. The main constraints are the number of medical staff and 
the earmarked monetary donations to open new treatment centers. The authors suggest several 
families of valid inequalities to hierarchically cut some sections of the feasible regions and speed up 
computational time. They compare the results of their model with other prevention strategies in the 
literature, including antibiotics, vaccinations, and provisions for clean water, in terms of death rate in 





7.5. Future Research Opportunities 
The research studies in this section investigate mass dispensing, vaccine SC coordination, food home 
delivery for the quarantined, and SC network design. The trend in SC configuration of modeling is 
similar to what is observed in ‘mitigation’ problems. The field has attracted attention for a decade. 
Various data types and analyses techniques have been used but mathematical modeling and F&A data 
are significantly more popular than the others. 
There are many possibilities for future research in pandemic SCs. We focus on two groups of 
vital items in medical SCs (e.g., vaccine and medication) and foods. The related SCs are global in 
which a number of nations are involved. Research is to determine if a country needs to optimize its 
resources at the outset of a pandemic and not share it with other nations. On the other hand, this 
approach may damage trust and long-term relationships in SCs. Keeping balance in such a situation 
can help to identify various research gaps. For example, countries locally can apply limitations to their 
import and export activities and may not be able to run their global SCs freely. When it comes to a 
domestic SC, last-mile delivery is the bottleneck. Research can help determine how to dispense food 
or medications best (e.g., how to deal with the distribution of a new vaccine). Research is warranted to 
better coordinate and integrate many public and private organizations' activities to optimize their 
potential abilities and skills for quickly dispensing new technologies and medicines. An attractive 
domain for future research exists in the intersection of psychological and physical fragility. 
 
8. Decision Support Systems for Managing Pandemics/Epidemics 
8.1. Mass Dispensing in Infectious Diseases 
Lee et al. (2006) develop a DSS for large-scale dispensing of medications in case of a biological 
attack and infectious disease outbreaks. The DSS uses an integer programming model for clinic 
design including its layout design and staffing. Modular design with possible scenarios in each 
module such as patient arrivals, triage, and orientation of rooms are considered. Efficiency measures 
such as the most efficient floor plan, the most cost-effective dispensing, and the smoothest operations 
(i.e., shortest average wait time, average queue length, equalized utilization rate) are evaluated for a 
combination of scenarios to choose the best one. The DSS is tested and validated, including what-if 
analysis, on an actual anthrax-treatment and smallpox vaccination using 864,000 households in 
Atlanta, USA.  
In contrast to Lee et al. (2006) which is dedicated to medications, Fogli and Guida (2013) 
propose a knowledge-centered DSS that can be used during a pandemic alert, pandemic, and post-
pandemic periods. An emergency scenario is defined by various factors such as population size, 
institutional participation, operational involvement, and emergency management units. The DSS 
architecture has three layers: knowledge and data layer, application, and user interface. In the 
knowledge and data layer, database, document-base and knowledge-base exist. In their experiments, 




in Italy.  
 
8.2. HIV/AIDS  
Rauner (2002) designs and implements a DSS for resource allocation for HIV/AIDS control programs 
that works based on a system dynamics model and simulation. The system dynamics model consists 
of several compartments showing different populations in terms of their health situation (infected or 
non-infected), gender, age, behavior (i.e., intravenous drug user, homosexuality, or prostitution), 
testing status, etc. and the ways the virus is transmitted from one group to another. The authors 
successfully tested their model based on real data in Vienna, Austria, to achieve cost-effective 
solutions for drug treatment, additional therapies and HIV screening. The DDS can help a local 
government analyze various resource allocation scenarios and decide how to proceed based on the 
possible consequences. 
Following Rauner (2002), Rauner et al. (2005) design a discrete-event simulation model to 
evaluate two intervention strategies with different fixed and variable costs and benefits: (1) anti-
retroviral treatment (ART), which is applied at childbirth, and (2) bottle feeding instead of 
breastfeeding. ART needs a combination of medicines, which is not a cure but can help infected 
people live longer. Bottle feeding is a replacement for breastfeeding – and can increase mortality 
compared to breastfeeding (Coutsoudis et al. 2012) – that can be applied at delivery, at three months, 
or six months. The authors model the problem, using systems dynamics modeling– by splitting the 
population in terms of their age, maternal stage (pregnant or breastfeeding), etc. – and solving it using 
a Markov chain simulation. The model is tested on data from rural Tanzania.  
Heidenberger and Flessa (1993) explain that the pattern of AIDS in sub-Saharan Africa (so-
called pattern 2) is different from HIV in the United States (so-called pattern 1). In pattern 1, male 
homosexuals and drug users are mainly involved. In pattern 2, HIV is mostly diffused through 
heterosexual intercourse. Unlike pattern 1, in pattern 2, children are also involved through their 
mothers and contaminated blood in hospitals. Besides, most of the population in pattern 2 live in rural 
areas (around 75%). Four layers are defined for the population: level 1 (age, sex, urban, and rural 
areas), level 2 (children), level 3 (healthy, HIV+ and AIDS; HIV+ is further divided into short or long 
incubation period), and level 4 (time since the acquisition). The links between groups over time have 
been considered. Based on data from the literature and survey in Tanzania and opinions of AIDS 
experts, a system dynamics model is used to learn how the transmissions happen among different 
groups. The model can evaluate the efficacy of intervention strategies and forecast future strains for 
resource allocation.  
Harper and Shahani (2003) design a DSS for predicting the future number of HIV/AIDS patients. 
The DSS works based on a simulation model and considers the historical chronology of different 
subgroups/ populations as asymptomatic, early stage, intermediate stage, and AIDS. Then, it helps 




The model has the flexibility to accommodate some changes. For example, in the case study, high-
income and low-income groups are separated. Also, in the case study, the DSS estimates the required 
budget for a clinic over the next ten years.  
 
8.3. School Closures 
Araz et al. (2013) design a DSS to investigate the problem of school closure planning in the case of a 
pandemic. WHO recommends school closure in the early stages of a pandemic. This is a challenging 
decision due to its direct and indirect economic impact, such as student meals and education delivery. 
The authors consider an area with several counties and various types of schools in each county, 
including preschool, elementary school, middle school and high school. A disease can be transferred 
from one county to another and also between schools in a county. The authorities decide between (i) 
early closure/ limited re-opening and (ii) sequential closure/re-opening to minimize (1) the total 
number of infections in the schools and (2) discontinuity in education. The authors use the SEIR 
transmission model and employ simulation to analyze it based on an exercise scenario and implement 
it on data from the 2009 A/H1N1 influenza outbreak in Arizona, USA. The findings of their research 
show that decision (ii) is preferred. 
 
8.4. Community-based Collaboration 
Li et al. (2014) suggest setting up a collaborative information system in emergencies but the authors 
believe the system can help in a disease outbreak. The research suggests using an information system 
to maximize the utilization of the available resources. The system is community-based and uses a 
Multi-Criteria Decision Making (MCDM) tool. Stakeholders such as local authorities, NGOs, police 
and fire departments, public and private organizations in a community share their data in a “ground 
zero” situation. Such a system can help increase awareness, mobilize, and make appropriate decisions 
based on local knowledge and resources. In designing the system, the authors adopt the W3C 
Emergency Information Interoperability Framework which stands for “who-what-where.” In this 
taxonomy, stored data such as capabilities, resources, and locations are acquired from appropriate 
organizations in the communities. A pilot is implemented to show the system can collect and integrate 




Han et al. (2019) investigate the integration of crowdsourcing and the Internet of Things (IoT) which 
brings together social media and RFID technology in disaster response by a simulation model. While 
the focus of the paper is not on epidemic/ pandemic outbreaks, the authors perceive similarities 
between the SIR model and disaster response. They urge researchers to investigate its application in 





8.6. Foot-and-Mouth Disease  
Ge et al. (2014) develop a decision support framework for foot-and-mouth disease (FMD) which 
arises from livestock production. The framework works at the strategic, tactical and operational levels, 
so-called multi-level hierarchical Markov processes (MLHMP) and is applicable to contagious 
diseases such as classical swine fever and avian influenza. Decisions made at each level depend on the 
higher level. The level of uncertainty in the lower decision-making levels is less than in the higher 
levels. The decisions and states can be time horizons, stage lengths, level-specific actions, etc. 
Strategic processes involve decisions about using preventive vaccination. Tactical levels involve 
implementing additional measures (e.g., pre-emptive culling), emergency vaccination or 
implementing compulsory measures. The operational level decides whether to start or continue the 
program. To solve the problem under uncertainty, a Bayesian forecasting method is implemented that 
is based on learning over time.  
 
8.7. Future Research Opportunities 
The DSS discussed in this section focus on mass medical dispensing, resource allocation, disease 
prevention or slowing down disease transmission, school closures, community-based collaboration, 
crowdsourcing, and emergency vaccination. Disease-specific research mostly focuses on HIV/AIDS, 
H1N1, anthrax, and smallpox. Simulation is the most popular technique in the model base because it 
provides the ability to conduct scenario analysis. Moreover, the related databases are supported by 
F&A. In the future, the increasing power of computers and availability of data generated through 
information technology will create stronger DDSs.  
We observe that medical DSSs for managing pandemics/epidemics are highly developed for 
HIV/AIDS because there are rich databases for various countries. Extending such DSSs for other 
diseases has not been accomplished. For example, this model might be useful for observing the impact 
of a vaccine or a disease suppressor (neither of which yet exist). Another research opportunity is to 
develop robust quantitative DSS models. Currently, the predominant models use system dynamics and 
simulation as their primary technique. An important aspect of designing an efficient DSS is 
computational time, as we are dealing with complicated models and large databases. Therefore, 
developing efficient solution techniques is critical, particularly with a DSS that requires rapid 
operational decisions compared to strategic decisions involving long planning horizons. 
Providing what-if analyses is an important feature embedded in some research studies. This 
needs to be continued to cope with uncertainties. Only one of the papers in this section uses an 
MCDM technique which is appropriate to observe the changes in conflicting criteria when evaluating 
various scenarios. In the future, researchers can increase their effectiveness by efficiently solving DSS 
models combined with MCDM techniques (Gutjahr and Nolz, 2016). Research should also be 




various vaccines. As was previously noted, such analytics do not yet exist for vaccines or for various 
disease suppressors. 
 
9. Risk Assessment 
9.1. Performance Measures for HIV/AIDS 
Zanakis et al. (2007) asses the efficiency of 116 countries in controlling HIV/AIDS. They investigate 
the relationship between economic development, migration and the nation’s health performance with 
HIV/AIDS epidemics. The researchers consider many independent variables and shortlist dependent 
and exploratory variables. They apply data envelopment analysis (DEA) to assess each country's 
output based on their inputs. The research findings show that nations with lower population density 
provide better health performance and superior per capita support. Nations that are not rich but still 
have high performance provide better media information and lower HIV/AIDS indicators. The authors 
suggest a multi-national collaboration to improve performance measures for the HIV/AIDS pandemic. 
 
9.2. Social Amplification of Risk 
Busby and Onggo (2013) investigate the concept of social amplification of risk that does not explicitly 
focus on disease outbreak but it can be used for that purpose. The research deals with social processes 
where risk perception is exaggerated or underestimated. The authors use system dynamics to model 
this qualitative problem for risk perception and risk communication. They develop three models: the 
traditional view based on social risk amplification (basic model), adding an attributional subsystem to 
the basic model, and adding complexity to the basic model. Real data are collected from people 
involved in studying zoonotic outbreaks. These people are divided into an expert group and a lay 
group. The findings show that expert people systematically find explanations to exaggerate or 
underplay their views. Neither group tries to correct their own initial beliefs. Therefore, social 
amplification based on subjectivity in different actors magnifies polarization. 
 
9.3. Ebola Risk Assessment 
Powell et al. (2018) study the role of systems knowledge in identifying and assessing risk, focusing on 
the Ebola outbreak. The authors believe that comprehensive systems knowledge should include 
dynamic behavior, the role of human agents, and the availability of knowledge to the agents. 
Accordingly, they suggest a system to comprise these factors contrasting, information, knowledge 
used in a system, knowledge about the system and the knowledge placed in a system. The researchers 
suggest a procedure that works based on influence diagrams and system dynamics as a qualitative 
technique to identify risks and suitable risk management policies. Based on data from the Ebola 
outbreak in West Africa, they show how the procedure works and explain its usefulness. 
 




In this section, the papers that study risk assessment in pandemics/epidemics focus on HIV/AIDS and 
Ebola in one or more nations. DEA and system analysis are the preferred techniques. Risk assessment 
for pandemics/epidemics by OM scholars is an under-explored area. The existing research is mostly at 
a national level (except one). In the future, we need more global research in which different countries 
are compared and contrasted. 
Possible research could focus on applications in a single country or across multiple countries. In 
single-country research, risk assessment is closely linked to social and behavioral aspects which are 
difficult to quantify. That is why existing papers use qualitative data analysis methods. Research 
across several countries is illuminating as it compares and contrasts actions taken by various nations 
in controlling an outbreak. Techniques used for measuring productivity such as DEA can be 
reasonable. However, research in the field requires a high volume of empirical data that may not be 
readily available. Further, there may be issues with data accuracy as different nations have different 
transparency levels leading to invalid analyses. Of great potential value is research on the effects of 
bias wherein experts provide explanations that systematically amplify or underplay the seriousness of 
situations.  
 
10. Implications for Managers 
Most of the research reviewed in this paper is based on real-life case studies; and real and archival 
data. Therefore, the research is practical, useful, and impactful for everyone in the world. However, 
COVID-19 is a different beast and a dangerous one; more furious than a category five hurricane. The 
current generation has not experienced a pandemic of this size before. The whole world is engulfed in 
the fury of this disaster. To list a few, never before, anyone has witnessed school closures, business 
closures, ban on national and international travels, and the complete lockdown of some countries for 
months. Vaccine is not available and its distribution logistics is not known. Because of the shutdown, 
providing food and groceries to households has gained significant importance. Hospitals are not able 
to manage the surge in demand.  
Since COVID-19 has impacted all lives around the world, everyone becomes a stakeholder in 
sharing the benefits from pandemic research. However, we have grouped stakeholders into the 
following categories: National Policy Makers, Healthcare (including hospitals) Administrators, 
Business Executives, School Administrators, and Researchers. In Table 1, we list various issues that 
are important for these stakeholders based on the lessons learned from the models, frameworks and 
empirical studies available from prior research; and the research directions provided in Section 11, 





Table 1: Stakeholders and Relevant Issues 
Stakeholder Relevant Issues 
National Policy 
Makers 
Business closures, school closures, mitigation and interventions, lock-downs, impact of 
national culture, food stockpiles, social unrest, travel restrictions, global and domestic 




Monitoring warning signals, disease prediction, disease spread, healthcare policies, 
vaccine development, vaccine stockpiling and distribution, hospital capacity and bed 
allocation, mitigation strategies, mass dispensing and immunization, health-related 
donation, treatment prioritization, co-epidemics, and the ability to understand and deal 
with risk amplification.  
Business Executives Implications of dividing businesses into essential and non-essential, SC for vaccines, 
knowledge of how to ramp up manufacturing capacities, logistics of food home 
delivery, bioterror through commercial SC 
Educational 
Administrators 
Education delivery (online, face to face, hybrid), class schedules, international 
students, management of dorms including food services 
Householders Medicine home stockpiling, quarantine and shielding, community-based collaboration, 
knowledge of how to assist disease tracing  
Researchers All issues listed above and described in detail in Section 11, Conclusions and Future 
Research Directions 
 
11. Conclusion and Future Research Directions 
Our review of research on pandemics/epidemics identifies research problems, research questions, data 
types, data analysis techniques, and disease types, therapeutics and vaccines. The research findings 
and future research directions are discussed in each section. In addition, we discuss below potential 
research topics that are important in the short run to manage COVID-19, and future pandemics in the 
long run. We have divided our recommendations into the following groups: (A) Disease Prediction, 
(B) Mitigation and Interventions, (C) Socio-political and Economic Consequences, (D) National 
Culture, (E) Resource Planning, and (F) Analytical Techniques. 
 
A. Disease Prediction 
Most of the papers discussed in our review are disease specific and are likely to become part of 
archives having only historical significance once the disease is eradicated. However, their research 
findings can be extended to predict and cope with future diseases. As we learned, the original SIR 
models were extended to SEIR, and SIS, etc. New models are required for the COVID-19 pandemic. 
For example, a forced Susceptible-Exposed-Infected-Recovered-Dead (fSEIRD) model implemented 
in Italy is claimed to be more realistic for this disease (Piccolomini and Zama 2020). New prediction 
models are required as COVID-19 still persists and its duration is uncertain (Scudellari 2020). The 
spread of COVID- 19 appears to be going in waves. Yet, this description is controversial because 
variables such as weather and various lock-down rules may be seen as factors that modify the same 
single onslaught of the disease over time and various places. It is important to study all relevant 
factors that lead to this variability to predict an end.  




Building trust and collaboration between countries could contain the outbreak and mitigate 
consequences (McCloskey et al. 2014).  
• The existing disease spread models are mostly at urban levels. There are some community-based 
models where a community is defined based on disease type (e.g., HIV community). COVID-19 
revealed that there are many confined communities (e.g., universities) that need models to support 
their decisions such as crowd sizing (identifying event crowd-size restrictions for different groups, 
e.g. in university or school), university start time, hospital surge planning etc. (Kaplan 2020). 
• Demographics play an important role in susceptibility, as well as which agents spread diseases. It 
appears that various population segments have superior immunity to symptoms and are therefore 
efficient asymptomatic carriers of contagious diseases. Who are they? Different disease patterns apply 
to various age groups, blood types, DNA characteristics, and gender. This is a research domain 
(medical, pharmaceuticals and OM-oriented) of great significance which must include the impact of 
enormous technological change that is likely to accelerate in the near future. Cooperative multi-
disciplinary efforts need to be brought to bear and research is warranted on how to achieve this goal. 
 
B. Mitigation and Interventions 
Pharmaceutical and non-pharmaceutical interventions are essential to contain the spread of disease. 
OM researchers will find many important and interesting avenues for research in this area. 
• Vaccine development lies in the domain of medical research. However, after a safe and effective 
vaccine is developed and approved by the authorities (e.g., Food and Drug Administration in the 
U.S.A.), OM researchers can make contributions by analyzing a variety of related problems that fall 
within the domain of capacity planning and logistics. For example, the optimal quantity of vaccine to 
be manufactured needs to be estimated. Manufacturing facilities must have appropriate capacity to 
produce these vaccines on both, regional and global levels. Underproduction will leave populations 
unprotected; over-production will lead to unnecessary cost, increased hazardous waste, and severe 
opportunity costs for misplaced efforts. This production capacity, released by reducing 
overproduction, could have been allocated to developing beneficial pharmaceuticals. Allocation of 
vaccine among different countries, to different regions within a country, and among different 
segments of populations (by age, ethnicity, and medical conditions) needs to be determined. Logistics 
of distribution and SC management are also important so that the vaccine reaches those who will 
benefit the most as quickly as possible. In preparation for research along these lines, it will be useful 
to read more about vaccine allocation and distribution issues in Branswell (2020) and WHO (2020). 
• Timing of non-pharmaceutical interventions is important to contain pandemics and is an important 
research topic. Governments around the world assessed the potential for harm in different ways and 
employed different strategies considering their culture, political orientation, skills and resources to 




lockdown strategies at early stages while others did not enforce such measures or did so at later 
stages. Some countries started mass testing of those suspected of being infected and others advised 
people to delay treatment for days after experiencing symptoms due to lack of healthcare resources 
and/or test kits. Some authorities distributed PPE (personnel protective equipment) (such as N95 
masks) among frontline healthcare providers, some enforced quarantine regulations, and some started 
to construct new hospitals at very early stages. Obviously, at the international, national and state 
levels, there has been a clear lack of proven plans in place at strategic, tactical and operational levels 
to be implemented effectively. Study of these issues is essential to develop effective national policies 
to cope with pandemics. 
• Decisions regarding closing and reopening of educational institutions, including universities and K-
12 schools, need to be systematically investigated with respect to all relevant variables. We have not 
found any substantial efforts in this regard. In particular, school and nurseries' closure may affect 
working parents, teachers, and a variety of adults who interact in different ways with each particular 
situation even if their business is still running (Chin et al. 2020).  
• Impact of travel restrictions within a country and across country borders needs more investigation.  
• Acquiring precise and quick knowledge about the nature of diseases in terms of (i) being viral or 
bacterial, incubation period, transmission mode (e.g., airborne or droplet), etc., (ii) existence or lack 
of a vaccine before infection, and (iii) existence or lack of treatment after infection are pre-requisite 
for the members in a healthcare SC. Then, practitioners in the related SC can utilize OM concepts to 
decide about inventory, staffing, mass vaccination, and so on.  
 
C. Socio-political and Economic Consequenes 
COVID-19 has far reaching social, political and economic impacts. A study of these impacts is 
essential to minimize adverse effects on society and economy. 
• Social unrest, likely to be created by a pandemic, is an important research topic. A pandemic was 
the cause of ‘collapse of social cohesion’ as discussed in section 4.5 (Carvalho-Rodrigues et al. 
(1993)). If COVID-19 is not contained, it may lead to societal breakdown; and create social and 
financial crises. Research shows that “the probability of riots, violence against civilians, food-related 
conflicts, and food looting has increased since lockdowns” (Roxana Gutiérrez-Romero 2020). 
Psychological impact of a pandemic is an important research topic. In preparation for research along 
these lines it will be useful to read more about social unrest due to COVID-19 (Tomic 2020; Galea 
and Abdalla 2020). 
• Economic impact of business closings is an important research area (Atlas et al. 2020 and Porter 
2020). The research issues include among others: determining times for closing and reopening, impact 
on employees’ morale and financial status, impact on small as well as large business owners, 




reopening. There is also the extent to which employees work from home and how that condition 
persists after re-opening. 
• Managing COVID-19 seems to have become a socio-political issue, at least in the U.S.A. How does 
the political governance system influence decisions and plans to contain the spread of the disease? 
The study of the decision-making style of political leaders is important. Carey (2020) has found that 
nations with female leaders performed better than others in combatting the COVID-19 pandemic. 
More research is needed to test the assertion that the gender of a country leader may affect the control 
of disease spread.  
 
D. National Culture 
• Compliance with recommended or mandated non-pharmaceutical interventions, like social 
distancing, wearing masks, quarantining, isolation, contact tracing, etc. will be different across nations 
because of national culture (Gupta and Gupta, 2019). Impact of culture on the enforcement of such 
decisions needs to be studied. Also, there are contradictory opinions about the effectiveness of these 
measures on disease spread. Some believe that these opinions are politically driven; others contend 
they are data driven. Research is needed to bridge this gap. 
 
E. Resource Planning 
• Building surge capacity for healthcare resources is an important topic for research. For example, 
shortage of ventilators, ICU beds, PPE during the initial phases of the COVID-19 pandemic was a 
major problem faced by hospitals in the U.S.A. as well as many other parts of the world. During 
COVID-19 the hospitals are dealing with pandemic as well as regular patients. Distribution of hospital 
capacity among these two groups is an important area of research. Klein et al. (2020) provide a 
systematic review of many existing surge capacity models and show that just a few of them can help 
healthcare systems respond to COVID-19 or similar pandemics in a practical way.  
• Study of SC disruptions, particulary in the food industry at the retail level is important. Grocery 
deliveries to households have become an important fallback during the pandemic. How to stockpiles 
food supplies is an important area of pandemic research. 
 
F. Analytical Techniques 
• Stochastic modeling and statistical analysis have been frequently used at tactical and operational 
levels. Simulation was used for prioritizing treatment, staffing decisions at mass immunization, 
vaccine allocation, school closures, treatment policies, disease spread, mass dispensing of 
medications, DSS design, and resource allocation. Stochastic modeling was utilized in disease 
progression, DSS design, vaccination prioritization and quarantine programs. Statistical analysis was 




design, and socio-economic studies.  
• However, the problem at hand is very complex and an optimization model may not be sufficient. 
Applications of systems dynamics and system simulation need to be explored. Appropriate decision 
support systems have to be developed that can provide decision-making tools for administrators. 
Interestingly, unlike what is observed in other disasters (Gupta et al. 2016; Gupta et al. 2020), most 
pandemic/epidemic research is based on primary or secondary data. Therefore, these datasets can also 
support empirical research in the future. Application of new techniques like machine learning, text 
data mining, and artificial intelligence (AI) methods taken broadly, need to be explored. Perhaps, the 
main change over recent years is the availability of internet-derived large databases as the source of 
empirical data. So empirical research to discover “clusters” in models can help. For example, a cluster 
of people from a certain religious group could be linked to a specific church in South Korea. Such 
empirical data can also help develop more advanced machine learning and data mining techniques 
such as clustering, dimensionality reduction, structured prediction, anomaly detection, artificial neural 
network analyses, etc. 
• Information technology is much more advanced now than it was during past pandemics. We have an 
opportunity to harness the power of computing, data availability and mathematical modeling to 
analyze these very complex problems (Keskinocak and Savva 2020). We have previously discussed 
some information technology applications in pandemic/epidemic research such as DSS and 
surveillance. These applications can be extended, for example, in containment and mitigation stages. 
It is important to trace movements of some of the infected people to identify the affected clusters to 
which they belong. The movements and contacts of infected people can be traced back through their 
mobile phones and credit cards. However, this raises privacy issues. POM research needs to examine 
tradeoffs between better health and less privacy. Importance of developing DSS in real time (called 
scratch modeling) has also been stressed by Kaplan (2020). Abundance of data generated through 
information technology can support data-driven models, for example, to forecast disease transmission 
(Paiva et al. 2020). 
 
In conclusion, we assert that managing pandemics/epidemics is a very complex endeavor because 
medical, political, social, demographic, cultural, healthcare (including assisted living communities) 
and behavioral factors interact with each other. Multi-discipline collaboration between experts in a 
variety of interactive fields, with POM researchers at the center stage, can generate effective and 
efficient alternatives. We also suggest undertaking focussed surveys on the issues raised in this 
section and including journals from all relevant disciplines.  
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APPENDIX A: Pandemics/Epidemics – A Historical Perspective 
The human race has witnessed and overcome many deadly pandemics over the last several 
hundred years. “Cholera, bubonic plague, smallpox, and influenza are some of the most brutal killers 
in human history. And outbreaks of these diseases across international borders, are properly defined 
as pandemic, especially smallpox, which throughout history, has killed between 300-500 million 
people in its 12,000 year existence.”(MPHonLine, 2020b). Ten of the world’s deadliest pandemics 
include the following: disease name, (year, estimated death toll), Antonine Plague (165 AD, 5 
million), Plague of Justinian (541-542, 25 million), The Black Death – Bubonic Plague (1346-1353, 
75-200 million), Third Cholera Pandemic (1852- 1860, 1 million), Flu Pandemic (1889-1890, 1 
million), Sixth Cholera Pandemic (1910-1911, 800,000+), Flu Pandemic (1918, 20-50 million), Asian 
Flu (1956-1958, 2 million), Flu Pandemic (1968, 1 million), HIV/AIDS Pandemic (identified in 1976, 
36 million since 1981) (MPHonLine, 2020b). Some of the more recent outbreaks include SARS in 
south China (severe acute respiratory syndrome) between 2002 and 2004, 2009 swine flu in Mexico 
City, Ebola in West Africa between 2014 and 2016, and cholera (after the Haiti earthquake between 
2010 and 2019). COVID-19, declared to be a pandemic by World Health Organization on March 
11, 2020, is an ongoing pandemic. The pandemic, with its origin in China, is also known known as 
coronavirus. The viruse spreads through air, droplets and aerosols, usually when people are in close 
distance. Figure A1 shows the growth in number of pandemic cases world wide since its outbreak.  
 
Figure A1: Total Number of COVID-19 Cases Worldwide 
Source: Our World in Data; https://ourworldindata.org/coronavirus-source-data 




APPENDIX B: Description of Diseases 
Diseases are caused by pathogens that include bacteria, viruses and parasites. Since 1970, over 
1,500 pathogens have been discovered; 70% of them originated from animals (WHO, 2018). 
Smallpox, different types of flu, measles, hepatitis, rabies, Ebola, HIV/AIDS, SARS, Ross River and 
Foot-and-mouth disease (FMD) are examples of diseases caused by viruses (Medical News Today, 
2017)). Cholera, anthrax, plague, tuberculosis and cutaneous leishmaniasis are examples of diseases 
caused by bacteria (Stevenson, 2020). Unlike bacteria, viruses cannot survive without a living host. 
Only some bacteria are harmful but most viruses can cause disease (HealthyMePA, 2017)). A 




study, we found 51 papers that focus on viral diseases, 9 papers on bacterial diseases, 2 papers both 
(viral or bacterial) and 18 papers discuss general diseases. Thus, 80 diseases are discussed in 75 
papers; the discrepancy is because some papers study more than one disease.  
Of the virus-based diseases, the first disease-specific paper on swine flu (H1N1) was published in 
1983. We observe that HIV/AIDS (16 papers) and influenza (14 papers) have drawn the most 
attention of researchers. From Table A1, in Appendix A4, we also note that investigating HIV/AIDS 
has interested researchers since it was clinically observed in the early1980s. Swine flu research 
received attention in 2012 after the swine flu pandemic in 2009. Similarly, Ebola attracted attention 
after the Western African Ebola epidemic (2013–2016).  
Of the bacteria-based papers, we found one paper on plague, three on anthrax, two on cholera, 
and two on tuberculosis. Most of these diseases have existed for centuries so we include here a brief 
history of these diseases. Plague (aka Black Death) is caused by rodent fleas biting humans (See 
details in plague, 2020). The outbreak of plague started in the14th century and continued until the 17th 
century. The paper on the plague uses the data recorded during those centuries and its focus is on the 
collapse of some societies due to the plague (Carvalho-Rodrigues et al., 1993). Cholera has existed for 
many centuries, but its outbreak in India in 1817 brought the disease to prominence (History.com, 
2017). This outbreak was followed by several cholera pandemics killing millions of people around the 
world. The seventh cholera pandemic includes South Asia (1961), Africa (1971) and the Americas 
(1991). The most recent cholera outbreak in Haiti in 2010 gave impetus to research on cholera 
outbreaks (WHO, 2019). Cholera is considered to be endemic in many countries. Endemic relates to 
an infection that is constantly maintained at a baseline level in a geographic area without external 
inputs. 
Anthrax and tuberculosis are also ancient diseases dating back to the era before Christ (B.C.). The 
study of anthrax is important because it has been observed in some areas sporadically (e.g., a few 
cases in the UK among heroin addicts in 2009). Moreover, it is one of the deadliest diseases which 
can be developed in simple laboratories making it a potential weapon for bioterror attacks (Brandeau, 
2019). The history of anthrax including its attack on America in 2001, can be found in CDC (2016). 
The history of tuberculosis can be found in Barberies et al. (2017). A vaccine for tuberculosis is now 
available and it is no longer considered to be a major threat. However, it is still important because of 
the simultaneity of co-epidemics between HIV and tuberculosis. More research papers can be found 
on each one of these diseases in epidemiology and public health journals. Some of the important 
journals from these disciplines include: American Journal of Epidemiology, American Journal of 
Public Health, Annual Review of Public Health, Bulletin of The World Health Organization, Clinical 
Epidemiology, Emerging Infectious Diseases, Emerging Microbes and Infections, Epidemics, 
Epidemiologic Reviews, Epidemiology, European Journal of Epidemiology, Eurosurveillance, Health 
Services Research Journal, International Journal of Epidemiology, Journal of Clinical Epidemiology, 
Journal of Epidemiology and Community Health, Morbidity and Mortality Weekly Report (MMWR), 
Preventative Medicine, The Lancet. 
For all contagious diseases, the elapsed time between exposure to a pathogen and the appearance 
of its symptoms is called the incubation period. Incubation periods vary depending upon the type of 
pathogen. For example, incubation periods are 2 to 21 days for Ebola, 7 to 10 days for Lassa fever, 
less than a week for Zika, 1 to 5 days for seasonal/pandemic flu, 2 to 14 days for MERS, 2 to 3 days 
for Cholera, 24 hours for Plague (WHO, 2018). The range of estimated incubation periods for 
COVID-19 is from 2 to 14 days; it is on average 5 to 6 days (Worldmeters 2020b). The longer the 
incubation period, the more dangerous is the situation because an infected person is not aware that he 
or she has been infected, and is therefore more likely to infect other people who have not yet been 




APPENDIX C: Classification Frameworks 
There is no accepted scheme or framework for classifying research on pandemics. Frameworks 
differ across countries and across professional/health organizations. The classifications are also 
influenced by type of virus. For example, in the case of COVID-19, the UK National Health System 
(NHS) defines the phases as Contain, Delay, Research, and Mitigate (Commons Select Committee, 
2020). The World Health Organization (WHO), in the case of the 2009 pandemic H1N1, used the 
following phases (i) predominantly animal infections and few human infections, (ii) sustained human-
to-human transmission, (iii) widespread human infection (pandemic), (iv) possibility of recurrent 
events (post-peak) and (v) disease activity at seasonal level (post-pandemic) (WHO, 2009). In fact, 
WHO may release a phasing scheme for major pandemics by the nature of a virus. WHO defines the 
life cycle of a virus and its outbreak as follows (WHO, 2018): introduction/emergence, localized 
transmission, amplification, and reduced transmission immunity. For managing pandemics, the WHO 
suggests the following response interventions (WHO, 2018): Anticipation; Early detection; 
Containment; Control and mitigation; and Elimination or Eradication.  
 
APPENDIX D: A Macro-Level View of Pandemic Research 
We searched the literature using the keywords “Epidemic(s) or Pandemic(s) or Outbreak(s)” in 
the top operations management, operations research and management science (OM/OR/MS) journals 
listed in Gupta et al. (2016). We used SCOPUS as the search engine and looked for the keywords in 
the title, abstract and keywords of the articles. Our search spans from 1957 (the year in which the first 
issue of Management Science was published) through 2019. We found 107 papers and selected 75 of 
these papers for review in this paper. The list of the journals, the number of papers found in each 
journal are given in Figure A2.  
 
Figure A2: Count of pandemic/epidemic papers in the journal. 
 
The three-year moving average of the count of published papers, in Figure A3, shows the growth 
trend of pandemic research. This figure shows that researchers in the OM/OR/MS community started 
investigating the field of epidemiology in the late 1970s.  
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The count of papers by disease type is listed in Table A1. Papers that did not focus on any specific 
disease have been grouped under the general category. Disease-related research invariably gains 
momentum after the disease outbreak and due to the severity of the outbreak. The analysis techniques 
found include: simulation, mathematical programming, stochastic modeling, statistical analysis, 
system analysis, game theory, decision analysis, bayesian method, machine learning, graph/network 
theory and heuristics. Some papers developed Decisions Support Systems (DSS). The type of data 
used include; field & archival (F&A), hypothetical, and real. Some papers present case studies; and 
some use no data. Cross tabulations of this information are included in the following five tables: Table 
A2: Disease vs. Analysis Technique, Table A3: Disease vs. Type of Data, Table A4: Analysis 
Technique vs. Type of Data, and Table A5: Category vs. Type of Data, and Table A6: Category vs 
Analysis Technique. 
 
























































































General1 1 2 1  1   1      1     2   2  4  1 2 1 18 
HIV/AIDS      1 1  1 2 2 1 1  1 1 1 1 1 1    1     16 
Influenza               1  1 2 2 1  1 2 4     14 
Swine flu (H1N1)    1                  1 1 1    1 5 
Anthrax                1   1         1 3 
Ebola                           3  3 
H5N1 flu                     1  1    1  3 
Hepatitis C           1       1          1 3 
Cholera                           1 1 2 
Foot-and-mouth disease 
(FMD) 
                  1     1     2 
Smallpox                2             2 
Tuberculosis                  1  1         2 
Cutaneous leishmaniasis                           1  1 
Measles                    1         1 
Meningitis2                     1        1 
Plague         1                    1 
Respiratory, diarrhoea, 
and abdominal pain2 
                   1         1 
Ross River                    1         1 
SARS                         1    1 
TOTAL 1 2 1 1 1 1 1 1 2 2 3 1 1 1 2 4 2 5 7 6 2 4 4 11 1 1 8 5 80 
1 A general paper does not consider any specific disease(s). 
2 These diseases can be either viral or bacterial. 
3 Note: COVID-19 is not included in this table since the disease started in 2020. 
4. Note: The total number of papers in Table A1 is 80 because some papers have studied more than one disease. 
 
Table A2: Count of papers for disease type versus analytical technique.  














































































































HIV/AIDS 8 2 7 1 4 5       27 
General 4 8 6 2 1  1 1 1 1 1  26 
Influenza 3 4 4 2 1  2     1 17 
Swine flu (H1N1) 2 1  1    2     6 
H5N1 flu 2 2    1       5 
Smallpox 1 1 1  1        4 
Anthrax 1 1   1        3 
Ebola  2    1       3 
Foot-and-mouth disease (FMD)   1 1     1 1   4 
Hepatitis C 3            3 
Tuberculosis 2  1          3 
Cholera  2           2 
Meningitis 1 1           2 
Cutaneous leishmaniasis       1      1 
Measles    1         1 
Plague  1           1 
Respiratory, diarrhoea, and abdominal pain    1         1 
Ross River    1         1 
SARS  1           1 
TOTAL 27 26 20 10 8 7 4 3 2 2 1 1 111 
 
Note: COVID-19 is not included in this table since the disease started in 2020. 
 
Table A3: Count of papers for disease type versus type of data. 






























General 6 6 6 1  19 
HIV/AIDS 12 1  3 1 17 
Influenza 8 5 2   15 
Swine flu (H1N1) 5     5 
Ebola 3     3 
H5N1 flu 2   1  3 
Hepatitis C 3     3 
Tuberculosis 2   1  3 
Cholera 2     2 
Cutaneous leishmaniasis 1   1  2 
Foot-and-mouth disease (FMD) 1   1  2 
Smallpox 2     2 
Anthrax 1     1 
Measles 1     1 
Meningitis 1     1 
Plague 1     1 
Respiratory, diarrhoea, and abdominal pain 1     1 
Ross River 1     1 
SARS 1     1 
TOTAL 54 12 8 8 1 83 







Table A4: Count of papers by analysis technique vs. type of data. 
Data Analysis vs. 













































































































F&A 14 19 10 7 5 4 2 2 2  1 1 
Hypothetical 6 2 3 1 1 1 1 1     
No Data 1 4 7    1   1   
Real Data 4   1 2 3 1  1 1 1  
Case Study 1  1  1        
 
Table A5: Percentage of papers by type of data in each category. 
Category vs. Type of Data F&A Hypothetical No Data Real Data Case Study 
Warning Signals/Surveillance 57.14 14.29 - 28.57 - 
Disease Propagation 66.67 13.33 13.33 6.67 - 
Mitigation 58.82 17.65 23.53 - - 
New Product Development 50 25 25 - - 
Resource Management 85.71 14.29 - - - 
Supply Chain Configuration 66.67 16.67 8.33 8.33 - 
DSS for Managing Pandemics 58.33 16.67 - 16.67 8.33 
Risk Assessment 66.67 - - 33.33 - 
 
 
Table A6: Percentage of papers by analysis technique method in each category. 












































































































Warning Signals/Surveillance - 10 - 50 - - - 10 10 10 10 - 
Disease Propagation 5.26 36.84 42.11 - - 10.53 - - - 5.26 - - 
Mitigation 33.33 23.81 38.10 - - - - 4.76 - - - - 
New Product Development 60 - 20 20 - - - - - - - - 
Resource Management 75 25 - - - - - - - - - - 
Supply Chain Configuration 46.15 15.38 - - - - 30.77 - - - - 7.69 
DSS for Managing Pandemics 4.35 30.43 8.70 4.35 30.43 13.04 - 4.35 4.35 - - - 
Risk Assessment 20 20 - 20 - 40 - - - - - - 
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